login
  Password reminder
Vascular News
Contact the editor Visit Vascular News Twitter feed Visit Vascular News Facebook page
 

Long-term branch durability after complex aortic aneurysm repair reviewed


Thursday, 07 Jun 2012 18:30
Tara Mastracci
Tara Mastracci

Branches following complex aortic aneurysm repair appear to be durable and are rarely the cause of patient death following complex aortic aneurysm repair according to a study presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery.


Tara Mastracci, a co-author from the Department of Vascular Surgery at The Cleveland Clinic Foundation in Cleveland, USA, reviewed findings from her group’s study. The researchers gathered prospective data from 650 patients who underwent endovascular aortic repair with branched or fenestrated devices between 2001 and 2010.


“This physician-sponsored investigational device exemption trial included imaging studies and electronic records to supplement the dataset when necessary,” said Mastracci. “Branch stent reintervention, endoleak repair, stent fracture, migration, rupture and death were calculated. Time to event analysis was performed for a composite endpoint of reintervention for any branch. Univariable and multivariable analysis was performed to identify related variables and device failure was reported as a function of exponential decay to capture the loss of freedom from complications over time.”


Through nine years of follow-up (mean three years, standard deviation SD [2.3]) secondary procedures were performed for 0.6% of coeliac, 4% of superior mesenteric artery, 6% of right renal and 5% of left renal artery stents. Mean time to reintervention was 237 days (SD 354 days).


The 30 day, one-year and five-year freedom from any branch intervention was 98% (95% confidence interval [CI] 96–99%), 94% (95% CI 92–96%), 84% (95% CI 78–90%) respectively. Death resulted from branch stent complications in two patients, and was related to superior mesenteric artery thrombosis. Multivariable analysis revealed no factors as independent predictors of branch reintervention.


“The absence of long-term data on branch patency in open repair precludes comparison, yet the lower morbidity and mortality risk coupled with longer-term durability data will further alter the balance of repair options,” added Mastracci.

 

Source: Society for Vascular Surgery




Add New Comment

Most popular


Incraft low-profile endograft launched in Europe and Canada
Wednesday, 10 Sep 2014
Cordis announced on 10 September the launch of its Incraft AAA Stent Graft System, an ultra-low profile device for use during endovascular aneurysm repair (EVAR) for patients suffering from ... Incraft low-profile endograft launched in Europe and Canada

First patient enrolled in US study of Novate’s Sentry IVC filter
Monday, 22 Sep 2014
Novate Medical has announced that Souheil Saddekni, professor of Vascular and Interventional Radiology at the University of Alabama, Birmingham, USA, has enrolled the first patient in the SENTRY IDE ... First patient enrolled in US study of Novate’s Sentry IVC filter

First drug-eluting balloon approved in USA
Friday, 10 Oct 2014
The FDA has approved the Lutonix drug-eluting balloon for the management of peripheral artery disease. This is the first time that the agency has approved such a device for this indication in the USA. First drug-eluting balloon approved in USA

Features


Not all drug-eluting balloons are equal
Wednesday, 15 Oct 2014
Thomas Zeller, Bad Krozingen, Germany, analyses the results of two recent randomised controlled trials comparing drug-eluting balloons to angioplasty alone in femoropopliteal lesions. Not all drug-eluting balloons are equal

Renal stenting may benefit patients excluded from randomised trials, says expert consensus
Wednesday, 15 Oct 2014
Sahil A Parikh, Case Western Reserve University School of Medicine, Cleveland, USA, speaks to Vascular News about the Society for Cardiovascular Angiography and Interventions expert consensus on ... Renal stenting may benefit patients excluded from randomised trials, says expert consensus

Profiles


Martin Björck
Wednesday, 01 Oct 2014
Martin Björck, Uppsala University Hospital, Sweden, holds the only professor-chair of vascular ... Martin Björck

Cliff Shearman
Thursday, 03 Jul 2014
A former president of the Vascular Society of Great Britain and Ireland, Cliff Shearman was ... Cliff Shearman

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions